Understanding the estrogen receptor signaling pathway: focus on current endocrine agents for breast cancer in postmenopausal women-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Understanding the estrogen receptor signaling pathway: focus on current endocrine agents for breast cancer in postmenopausal women

Published:2011-08 Issue:8 Volume:8 Page:343-352
ISSN:1548-5315
Container-title:Community Oncology
language:en
Short-container-title:Community Oncology

Author:

Brufsky Adam M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference88 articles.

1. Endocrine therapy for the treatment of postmenopausal women with breast cancer;Harichand-Herdt;Expert Rev Anticancer Ther,2009

2. Tamoxifen for early breast cancer: an overview of the randomised trials;Lancet,1998

3. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;Forbes;Lancet Oncol,2008

4. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98;Coates;J Clin Oncol,2007

5. First mature analysis of the Intergroup Exemestane Study;Coombes;J Clin Oncol,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Estrogen Receptor Modulators (SERMs) for the treatment of ER+ breast cancer: An overview;Journal of Molecular Structure;2022-12

2. Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancer;The Breast;2014-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP